Thrombosis and Treatments Journal
Join a distinguished global community of hematologists, vascular medicine specialists, interventional cardiologists, clinical researchers, anticoagulation pharmacologists, coagulation scientists, thrombosis specialists, vascular surgeons, stroke neurologists, and translational scientists dedicated to advancing understanding of venous thromboembolism, arterial thrombosis, deep vein thrombosis, pulmonary embolism, antithrombotic therapies, anticoagulation management, coagulation disorders, thrombolytic interventions, and evidence-based thrombosis prevention through cutting-edge research, clinical trial findings, and collaborative scientific investigations worldwide.
Why Join Our Research Network?
The Thrombosis and Treatments Journal offers exclusive membership benefits to hematologists, vascular medicine specialists, interventional cardiologists, coagulation scientists, anticoagulation pharmacologists, thrombosis researchers, vascular surgeons, and clinical professionals advancing thrombosis research, evidence-based anticoagulation therapy, innovative treatment development, improved clinical patient outcomes, and delivery of comprehensive vascular care worldwide.
Reduced Publication Fees
Members receive up to 45% discount on article processing charges for all accepted manuscripts, making thrombosis research accessible to academic hematology departments, vascular medicine centers, research universities, clinical practices, pharmaceutical companies, and independent investigators conducting anticoagulation studies, thrombolytic research, and venous thromboembolism trials worldwide.
Unlimited Submissions
Submit unlimited research manuscripts annually with comprehensive double-blind peer review from leading thrombosis specialists, hematologists, vascular medicine physicians, and coagulation experts ensuring rigorous scientific evaluation, constructive feedback, methodological guidance, and adherence to the highest publication standards in thrombosis research.
Global Visibility
Your thrombosis research reaches hematology departments, vascular medicine centers, academic hospitals, pharmaceutical companies, biotechnology organizations, patient advocacy groups, clinical research organizations, and research institutions worldwide through extensive global indexing networks, search engine optimization, and open access distribution platforms.
Professional Recognition
Receive official membership certificate and digital credentials recognizing your commitment to thrombosis research for grant applications, academic promotions, tenure reviews, fellowship applications, research funding proposals, institutional affiliation verification, and professional portfolio documentation.
Priority Peer Review
Members receive expedited manuscript processing with priority scheduling from our distinguished editorial board of thrombosis experts, hematologists, vascular medicine specialists, coagulation scientists, and interventional cardiologists with extensive expertise in thromboembolic disorders.
Editorial Support
Access professional language editing, comprehensive manuscript formatting assistance, figure preparation, statistical consultation for clinical trials, graphical abstract design, and dedicated customer support from our editorial team throughout your membership period.
Select Your Membership Level
Flexible membership options designed for hematologists, thrombosis researchers, vascular medicine specialists, coagulation scientists, graduate students, postdoctoral fellows, academic institutions, pharmaceutical companies, and research organizations advancing thrombosis understanding, anticoagulation therapy development, thrombolytic treatment programs, and patient care outcomes improvement worldwide.
Graduate students, doctoral candidates, postdoctoral researchers, and early-career hematology researchers
- 30% APC Discount
- Unlimited Submissions
- Peer Review Access
- 1 User Account
Hematologists, vascular medicine specialists, thrombosis researchers and coagulation scientists
- 45% APC Discount
- Unlimited Submissions
- Priority Peer Review
- 1 User Account
Universities, academic medical centers, vascular centers and research institutes
- 45% APC Discount
- Unlimited Submissions
- Priority Peer Review
- 1-21+ User Accounts
Pharmaceutical companies, biotechnology organizations and clinical research firms
- 45% APC Discount
- Special Issue Access
- Priority Peer Review
- 10-15 User Accounts
How to Become a Member
Begin your membership journey with these three straightforward steps and start publishing your thrombosis research discoveries, anticoagulation therapy innovations, clinical trial findings, and therapeutic advances to our extensive global network of hematologists, vascular medicine specialists, thrombosis researchers, and coagulation scientists.
Choose Your Tier
Select the membership level that aligns with your thrombosis research needs, clinical specialty, career development stage, institutional budget, anticipated publication goals, research collaboration objectives, and collaborative research requirements.
Submit Application
Email [email protected] with your full name, academic credentials, institutional affiliation, hematology or vascular medicine research focus, thrombosis research publications list, and preferred membership tier selection.
Start Publishing
Receive your official membership certificate, digital credentials, professional recognition, and member portal access, then begin submitting manuscripts for expedited peer review, priority publication consideration, and accelerated editorial decisions.
Frequently Asked Questions
Find answers to common questions about exclusive membership benefits, manuscript publication process, peer review timelines, editorial guidelines, submission requirements, and support services for thrombosis researchers.
What research areas are covered?
The Journal welcomes original research on venous thromboembolism, arterial thrombosis, deep vein thrombosis, pulmonary embolism, antithrombotic therapies, anticoagulation management, coagulation disorders, thrombolytic interventions, platelet biology, fibrinolysis, stroke prevention, and thrombophilia genetics.
Can I upgrade my membership tier?
Yes, members can upgrade at any time during their active subscription period. Contact our dedicated membership services team for seamless tier transitions with prorated fees, updated benefits package, enhanced publication support, and continuous editorial assistance.
What is the peer review timeline?
Our rigorous double-blind peer review typically completes within 4-6 weeks. Members receive priority processing and expedited editorial decisions from our expert review board of thrombosis specialists, hematologists, vascular medicine physicians, and coagulation scientists.
Are clinical trial papers accepted?
Absolutely. We actively encourage submissions of Phase I-IV clinical trial results, real-world effectiveness studies, comparative anticoagulation analyses, patient-reported outcomes, long-term safety monitoring data, and antithrombotic efficacy studies.
How does open access benefit researchers?
Open access ensures your thrombosis research reaches hematology departments, vascular medicine centers, academic institutions, pharmaceutical companies, patient advocacy organizations, and research institutions worldwide without subscription barriers, maximizing research impact and citation potential.
What support services are available?
Members receive professional language editing, manuscript formatting assistance, figure preparation, statistical consultation for clinical trials, graphical abstract design, supplementary materials formatting, and dedicated customer support throughout your entire membership period.
Membership Renewal Guidelines
Maintain uninterrupted access to all exclusive member benefits, significant APC discounts, priority peer review processing, expedited editorial decisions, professional language editing services, dedicated editorial support, and comprehensive manuscript formatting support throughout your entire membership period.
Advance Thrombosis Research Today
Join the distinguished global community of hematologists, vascular medicine specialists, thrombosis researchers, coagulation scientists, anticoagulation pharmacologists, and interventional cardiologists advancing understanding of thromboembolic disorders, antithrombotic therapeutics, and evidence-based interventions worldwide. Start publishing your groundbreaking research with discounted APC rates, priority peer review, expedited editorial decisions, and worldwide visibility through our comprehensive open access publishing platform.